Becker's Healthcare July 30, 2024
Health systems spent 77% more on semaglutide, the active ingredient of Ozempic and Wegovy, between April 2023 and March 2024, compared to the prior year, according to Vizient’s Pharmacy Market Outlook.
Vizient evaluated the medication costs and utilization trends among its pharmacy program participants. Participants include hospitals, non-acute and pediatric care clients.
The report, published July 30, predicts a drug price inflation rate of 3.81% over the next 12 months. Experts at the healthcare data and analytics company also said they expect gene and cell therapies to pose increasing risks to health systems’ bottom lines.
Here are the top 15 medications by spend, along with their approved indications:
1. Humira (adalimumab) — Rheumatoid arthritis, Crohn’s disease and...
Today's Sponsors
Today's Sponsor